Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion

TW Prior, C Bartolo, AC Papp, PJ Snyder, MS Sedra… - Neurology, 1997 - AAN Enterprises
TW Prior, C Bartolo, AC Papp, PJ Snyder, MS Sedra, AHM Burghes, JT Kissel, MH Luquette
Neurology, 1997AAN Enterprises
Article abstract-The exon 45 deletion is a common dystrophin gene deletion. Although this is
an out-of-frame deletion, which should not allow for protein synthesis, it has been observed
in mildly affected patients. We describe a patient with an exon 45 deletion who produced
protein, but still had a severe Duchenne muscular dystrophy phenotype. RT-PCR analysis
and cDNA sequencing from the muscle biopsy sample revealed that the exon 45 deletion
induced exon skipping of exon 44, which resulted in an in-frame deletion and the production …
Article abstract-The exon 45 deletion is a common dystrophin gene deletion. Although this is an out-of-frame deletion, which should not allow for protein synthesis, it has been observed in mildly affected patients. We describe a patient with an exon 45 deletion who produced protein, but still had a severe Duchenne muscular dystrophy phenotype. RT-PCR analysis and cDNA sequencing from the muscle biopsy sample revealed that the exon 45 deletion induced exon skipping of exon 44, which resulted in an in-frame deletion and the production of dystrophin. A conformational change in dystrophin induced by the deletion is proposed as being responsible for the severe phenotype in the patient. We feel that the variable clinical phenotype observed in patients with the exon 45 deletion is not due to exon splicing but may be the result of other environmental or genetic factors, or both.
NEUROLOGY 1997;48: 486-488
American Academy of Neurology